Authors:
D'Arena, G
Musto, P
Cascavilla, N
Dell'Olio, M
Di Renzo, N
Perla, G
Savino, L
Carotenuto, M
Citation: G. D'Arena et al., CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia, LEUK LYMPH, 42(1-2), 2001, pp. 109-114
Authors:
Guglielmi, C
Martelli, M
Federico, M
Zinzani, PL
Vitolo, U
Bellesi, G
Santini, G
Tarella, C
Zallio, F
Pregno, P
Di Renzo, N
Resegotti, L
Citation: C. Guglielmi et al., Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas, HAEMATOLOG, 86(9), 2001, pp. 941-950
Authors:
Teofili, L
Di Febo, AL
Pierconti, F
Maggiano, N
Bendandi, M
Rutella, S
Cingolani, A
Di Renzo, N
Musto, P
Pileri, S
Leone, G
Larocca, LM
Citation: L. Teofili et al., Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease, BLOOD, 97(4), 2001, pp. 1063-1069
Authors:
Gobbi, PG
Broglia, C
Berte, R
Petrilli, MP
Molica, S
Angrilli, F
Iannitto, E
Ghirardelli, ML
Di Renzo, N
Cavanna, L
Ascari, E
Citation: Pg. Gobbi et al., Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease, HAEMATOLOG, 85(7), 2000, pp. 722-728
Authors:
D'Arena, G
Musto, P
Cascavilla, N
Dell'Olio, M
Di Renzo, N
Carotenuto, R
Citation: G. D'Arena et al., Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders, AM J HEMAT, 64(4), 2000, pp. 275-281